Passage Bio, Inc. Common Stock (NASDAQ: PASG) last traded at $4.44, down 0.89% on the session. The quote above updates while this page is open; the figures below are drawn from Passage Bio, Inc. Common Stock’s own filings and are restated only when a new one is published.
Passage Bio, Inc. Common Stock trades on NASDAQ under the ticker PASG. Its market capitalisation is $14.29 million.
Valuation measures for Passage Bio, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $14.29M |
|---|---|
| Enterprise value | $10.85M |
| Price / book | 3.21 |
| Beta | 2.69 |
Trailing-twelve-month figures tagged in Passage Bio, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) | -$36.11M |
|---|---|
| EPS (TTM) | -$11.32 |
| Return on equity | -810.41% |
| Cash | $24.16M |
Range and volume for PASG over the past 52 weeks.
| 52-week high | $20.00 |
|---|---|
| 52-week low | $3.29 |
| Volume | 36.1K |
| Average volume | 68.6K |
| Previous close | $4.48 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.